Patent Term Application for ZIIHERA® (zanidatamab-hrii), Patent No. 10,000,576 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-0372

Patent Term Application for ZIIHERA® (zanidatamab-hrii), Patent No. 10,000,576

Documents

Comments

Description

OPEN

Comment Period OpensFeb 4, 2025

Comment Period ClosesJun 3, 2026

Type	Title	Posted	Comments	Status
Other	Requests reconsideration and revision of the Determination of Regulatory Review Period from Ice Miller LLP (On behalf of Zymeworks BC Inc.)	Jul 16, 2026	--

CDER

Patent Term Application for ZIIHERA®

ICE Miller LLP

Zymeworks BC Inc

(zanidatamab-hrii)

Patent No. 10,000,576

OPEN